Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Migraine

  Free Subscription


Articles published in Rev Neurol

Retrieve available abstracts of 15 articles:
HTML format



Single Articles


    January 2024
  1. MINGUEZ-OLAONDO A, Lopez-Bravo A, Quintas S, Nieves-Castellanos C, et al
    [New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants].
    Rev Neurol. 2024;78:47-57.
    PubMed     Abstract available


    October 2023
  2. VINUEZA-BUITRON P, Montes-Pena VJ, Rodriguez-Mena D, Boada-Cuellar JL, et al
    [Habituation deficit study in patients with episodic migraine thru nociceptive blink reflex].
    Rev Neurol. 2023;77:159-165.
    PubMed     Abstract available


    June 2023
  3. GUEVARA-MARTINEZ E, Arjona-Padillo A
    [Complete remission of a migraine after treatment with cisplatin].
    Rev Neurol. 2023;76:375.
    PubMed    


    May 2023
  4. PEREZ-RODRIGUEZ A, Bandres-Hernandez P, Anciones C, Terron-Cuadrado C, et al
    [Cardiovascular safety of new drugs for the acute and preventive treatment of migraine: gepants and ditans].
    Rev Neurol. 2023;76:295-308.
    PubMed     Abstract available


    April 2023
  5. MADERA J, Rodriguez-Rodriguez EM, Gonzalez-Quintanilla V, Perez-Pereda S, et al
    [Peripheral stimulation of the trigeminal nerve by nasopharyngeal swabbing as a possible trigger of migraine attacks].
    Rev Neurol. 2023;76:227-233.
    PubMed     Abstract available


    March 2023
  6. FRESAN-RESTITUTO D, Lacalle-Fabo E, Martin-Bujanda M, Sarobe-Carricas MT, et al
    Non-responder migraine patients to a first anti-CGRP monoclonal antibody benefit from a switch to a second one.
    Rev Neurol. 2023;76:213-216.
    PubMed    


    January 2023
  7. DA SILVA CARDOSO J, Curto C, Manuel-Vieira P, Ashworth J, et al
    Primary headache with onset in childhood and adolescence: natural history and prognostic factors in a Portuguese population.
    Rev Neurol. 2023;76:9-14.
    PubMed     Abstract available


    August 2022
  8. LOPEZ-MORENO Y, Castro-Sanchez MV, Garcia-Trujillo L, Serrano-Castro P, et al
    [Failure of an anti-CGRP monoclonal antibody in the treatment of migraine. Is it worthwhile trying another one?]
    Rev Neurol. 2022;75:87-91.
    PubMed     Abstract available


    July 2022
  9. FERNANDEZ-GARZA LE, Marfil A
    Comorbidity between hypothyroidism and headache disorders in a Mexican population.
    Rev Neurol. 2022;75:13-16.
    PubMed     Abstract available


    May 2022
  10. JUICA-AVELLO S, Riquelme-Vergara C, Condeza-Riquelme F, Gonzalez-Burboa A, et al
    [Comparison of tiapride and topiramate in the prophylactic treatment of chronic migraine: a randomised, double-blind, pilot study].
    Rev Neurol. 2022;74:325-330.
    PubMed     Abstract available


    January 2022
  11. CASO-GONZALEZ A, Leralta-Gonzalez C, Sanz-Alonso V, Iturbe-Heras M, et al
    [Clinical experience with erenumab during the first year of treatment].
    Rev Neurol. 2022;74:8-14.
    PubMed     Abstract available


    June 2021
  12. LAINEZ-ANDRES JM, Ashina M, Belvis R, Diaz-Insa S, et al
    1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.
    Rev Neurol. 2021;72.
    PubMed     Abstract available


  13. MARIN-GRACIA M, Hernando-Quintana N, Lopez-Bravo A, Garcia-Arguedas C, et al
    [Degree of compliance with treatment at three months in migraine patients].
    Rev Neurol. 2021;72:377-383.
    PubMed     Abstract available


    February 2021
  14. MARTINEZ-PIAS E, Garcia-Azorin D, Trigo-Lopez J, Sierra A, et al
    [Chronic migraine with daily headache. Literature review].
    Rev Neurol. 2021;72:133-140.
    PubMed     Abstract available


    December 2020
  15. PLANCHUELO-GOMEZ A, Garcia-Azorin D, Guerrero-Peral AL, Aja-Fernandez S, et al
    [Response prediction for chronic migraine preventive treatment by gray matter morphometry in magnetic resonance imaging: a pilot study].
    Rev Neurol. 2020;71:399-406.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Migraine is free of charge.